Upcoming Submission Deadlines
Abstract Submission Deadline for #ECO2024 Sunday, January 14th 2024
We invite you to share your high-quality research and clinical work. E-posters will form an important part of the 31st European Congress on Obesity.
Save the Date #ECO2024
The 31st European Congress on Obesity (#ECO2024) will take place 12-15 May 2024 in Venice, Italy. Mark your calendars for this premier obesity event; register and secure accommodation early to avoid disappointment.
We look forward to hosting you in Venice!
Click here to learn more about ECO2024
EASO NEWS
Spotlight on EASO Adult COMs: Hasharon Hospital – Rabin Medical Center, Prof. Dror Dicker
Spotlight on EASO Adult COMs: Integrated Research and Treatment Center (IFB) Adiposity Diseases, Leipzig University Medical Center with Prof Dr Matthias Blüher, Prof Dr Michael Stumvoll, and Prof Dr Antje Körner
Spotlight on EASO Paediatric COMs: The Health School, Landspitali University Hospital, Iceland with Dr Tryggvi Helgason
SEEDO 2023
In November 2023, Seville hosted the XIX SEEDO National Congress, a major Spanish event in the field of obesity research and treatment. This congress brought together over 600 professionals, including endocrinologists, paediatricians, family doctors, nurses, nutritionists, dieticians, psychologists, and experts across various fields – all dedicated to health, prevention, and treatment of obesity-related issues.
New Global Obesity Consensus Statements
EASO is pleased to participate in the International Obesity Committee collaboration. Together we have developed recent statements on BMI, and on Weight loss vs Obesity Management.
Download the Body Mass Index Statement
Download the Obesity Care vs Weight Loss Statement
EASO Requests Regulatory Authorities to Review Governance and Practices Leading to Discrimination in Access to Effective Obesity Management
EASO is concerned that the European Medicines Agency and related national regulatory authorities (European Medicines Regulatory Network) governance is having a negative impact directly on people already under pharmacological treatment for obesity.
ECN SPOTLIGHT
Congratulations Thao Lam: 2023 EASO ECN Winter School Best Poster Winner
Thao developed a comprehensive index that quantified the obesogenic environment in the Netherlands.
UPCOMING EVENTS
SWEET EU Project: An Invitation to Our Final Stakeholder Event
Date: 18 January
Time: 12.00 – 17.00
Location: ILSI Headquarters
Av. E. Mounier 83 / B.6. B-1200 Brussels
New Course Offering From the RCSI School of Physiotherapy
EASO is pleased to share that the RCSI School of Physiotherapy is launching a set of new micro-credential courses, which represents a new academic offering from RCSI University of Medicine and Health Sciences.
5-day Accredited ASCEND Training Course
29 Jan – 2 Feb 2024, in Madrid, Spain
2024 Nordic Obesity Meeting
1–3 Feb. 2024 in Helsinki, Finland
Advanced Therapies for Pediatric Obesity (ATPO) Conference
21-23 February 2024 (Online)
EASL Liver Cancer Summit 2024
22–24 Feb. 2024 in Rotterdam, Netherlands, and online
EndoBridge 2024
17-20 Oct 2024 in Antalya, Turkiye
Clinical Case Submission Deadline:
23 Aug 2024
OBESITY FACTS JOURNAL
Volume 16, Issue 6, online first articles are all available open access.
- A Systematic Review and Meta-Analysis of Vitamin D Status of Patients with Severe Obesity in Various Regions Worldwide
- Bariatric Surgeries, from Weight Loss to Weight Regain: A Retrospective Five-Year Cohort Study
- Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults
- How Could Different Obesity Scenarios Alter the Burden of Type 2 Diabetes and Liver Disease in Saudi Arabia?
- Overweight, Weight Loss, and Self-Reported Global Life Satisfaction: The Lolland-Falster Health Study
- Comprehensive Questionnaire in Postpartum Women to Assess Women’s Knowledge of the Current Weight Gain Guidelines during Pregnancy in Lower Saxony
- The Fatty Liver Index, the Strongest Risk Factor for Low Testosterone Level
- The Causal Effect of Obesity on the Risk of 15 Autoimmune Diseases: A Mendelian Randomization Study
- Out-of-Pocket Expenses in Households of People Living with Obesity in France
ADDITIONAL RESOURCES
EU PROJECTS
SWEET PROJECT
The SWEET Project Newsletter for Winter 2023 is now available to read online.
BIO-STREAMS
Introducing Bio-Streams: Addressing Childhood and Adolescent Obesity in the EU
Bio-Streams, a new Horizon Europe Research and Innovation project designed to address the growing epidemic of underage obesity in the European Union, is excited to announce its official launch.
This groundbreaking project combines data-driven research, prevention measures and community participation to provide a holistic approach to reducing obesity rates among children and adolescents.
INTERACT EUROPE
Obesity is a chronic relapsing disease that acts as a gateway to other NCDs and is linked with an increased risk of developing breast, ovary, liver and colon cancer.
EASO is pleased to support the European Cancer Organisation-led Interact Europe project, which brings together 33 partners from 17 countries to develop a patient-centred European inter-specialty cancer training programme.
PREVENT EU
Proactive Strategies for Addressing Childhood Obesity and reducing Future Cancer Risks
EASO is delighted to partner with the European Health Management Association in a new project, PREVENT — improving and upscaling primary prevention of cancer by addressing childhood obesity through implementation research.
TIMESPAN
EASO is pleased to support this 5 year EU funded H2020 initiative. TIMESPAN, led by scientific coordinator Professor Henrik Larsson (Örebro University), includes 17 partners from across academia, industry, and patient advocacy communities, and aims to foster improvement in clinical management of adults living with with ADHD and co-occurring cardiometabolic disease, including obesity.